Rituximab‐related urticarial reaction overlying primary cutaneous follicle centre lymphoma: histological appearance and pathophysiological hypotheses

Diagnosis and Management of Cutaneous B-cell Lymphoma

“…Clinicians should be aware that case reports of localized edema or urticaria have been described in the CBCL skin lesions in these patients after systemic treatment with rituximab. 24,25 Patients with the development of extracutaneous disease should be treated as patients with nodal follicular lymphoma.…”

Dermatolojide Rituksimab Kullanımı

“…Mendes-Bastos ve ark ise otoimmun hemolitik anemisi olan bir çocukta rituksimab tedavisi sırasında tedaviyle ilişkili eritema annulare sentrifigum gelişimi gözlemişlerdir (15). İngen ve ark rituksimabla ilişkili ürtikeryal reaksiyon gelişimi tanımlamıştır (16). Dereure ve ark rituksimabla ilişkili vaskülit gelişimi gösteren bir olgu tanımlamışlardır (17).…”

Transient Wheal Attack Corresponding to the Tumor Lesions of Primary Cutaneous Diffuse Large B Cell Lymphoma, Leg Type after Successive Rituximab Treatment

“…In the present case, a wheal attack developed particularly at the site of tumor lesions, and those tumor lesions subsequently disappeared after rituximab monotherapy. Only a few cases of rituximab-related urticarial reactions have been reported in patients treated for B cell lymphoma [ 3 , 4 , 5 , 6 ]. Therefore, we would like to report a rare case and discuss the possible mechanism underlying rituximab-related urticarial reaction, which may improve the understanding of an unrecognized clinical effect of rituximab on tumors.…”